Striatal and extrastriatal dopamine transporter levels relate to cognition in Lewy body diseases: an (11)C altropane positron emission tomography study.
Autorzy:
Marquie M; Department of Neurology, Massachusetts General Hospital, 15 Parkman St., Boston, MA 02114 USA ; MassGeneral Institute for Neurodegenerative Disease, 16th St., Building 114, Charlestown Navy Yard, Charlestown, MA 02129 USA ; Autonomous University of Barcelona, Medicine Doctoral Studies, Doctoral School, U Building, Autonomous University of Barcelona Campus, Bellaterra (Cerdanyola del Valles), 08193 Spain. LocascioJJ; Department of Neurology, Massachusetts General Hospital, 15 Parkman St., Boston, MA 02114 USA. Rentz DM; Department of Neurology, Massachusetts General Hospital, 15 Parkman St., Boston, MA 02114 USA ; Department of Neurology, Brigham and Women's Hospital, 221 Longwood Avenue, Boston, MA 02115 USA. Becker JA; Department of Radiology, Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114 USA. Hedden T; Department of Radiology, Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114 USA ; Athinoula A. Martinos Center for Biomedical Imaging, 13th St., Building 149, Charlestown Navy Yard, Charlestown, MA 02129 USA. Johnson KA; Department of Neurology, Massachusetts General Hospital, 15 Parkman St., Boston, MA 02114 USA ; Department of Radiology, Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114 USA. Growdon JH; Department of Neurology, Massachusetts General Hospital, 15 Parkman St., Boston, MA 02114 USA. Gomperts SN; Department of Neurology, Massachusetts General Hospital, 15 Parkman St., Boston, MA 02114 USA ; MassGeneral Institute for Neurodegenerative Disease, 16th St., Building 114, Charlestown Navy Yard, Charlestown, MA 02129 USA.
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2014 Aug 27; Vol. 6 (5-8), pp. 52. Date of Electronic Publication: 2014 Aug 27 (Print Publication: 2014).
Adolescents' use of the built environment for physical activity.
Autorzy:
Oreskovic NM; Massachusetts General Hospital, Boston, MA, USA. .; Harvard Medical School, Boston, MA, USA. . Perrin JM; Massachusetts General Hospital, Boston, MA, USA. .; Harvard Medical School, Boston, MA, USA. . Robinson AI; Massachusetts General Hospital, Boston, MA, USA. . LocascioJJ; Massachusetts General Hospital, Boston, MA, USA. .; Harvard Medical School, Boston, MA, USA. . Blossom J; Harvard Center for Geographic Analysis, Boston, MA, USA. . Chen ML; Massachusetts General Hospital, Boston, MA, USA. .; Harvard Medical School, Boston, MA, USA. . Winickoff JP; Massachusetts General Hospital, Boston, MA, USA. .; Harvard Medical School, Boston, MA, USA. . Field AE; Harvard Medical School, Boston, MA, USA. .; Boston Children's Hospital, Boston, MA, USA. . Green C; Harvard Center for Geographic Analysis, Boston, MA, USA. . Goodman E; Massachusetts General Hospital, Boston, MA, USA. .; Harvard Medical School, Boston, MA, USA. .
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2015 Mar 15; Vol. 15, pp. 251. Date of Electronic Publication: 2015 Mar 15.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson's disease.
Autorzy:
Mittal S; Neurogenomics Laboratory and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA.; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.; Department of Neurology, Brigham and Women's Hospital, Boston, MA 02115, USA. Bjørnevik K; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.; The Norwegian Multiple Sclerosis Competence Center, Department of Neurology, Haukeland University Hospital, Norway. Im DS; Brain and Mind Research Institute, Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada. Flierl A; The Parkinson's Institute and Clinical Center, Sunnyvale, CA 94085, USA. Dong X; Neurogenomics Laboratory and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA.; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.; Department of Neurology, Brigham and Women's Hospital, Boston, MA 02115, USA. LocascioJJ; Neurogenomics Laboratory and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA.; Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA. Abo KM; Neurogenomics Laboratory and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA. Long E; Neurogenomics Laboratory and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA. Jin M; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.; Department of Neurology, Brigham and Women's Hospital, Boston, MA 02115, USA. Xu B; Department of Pharmacology, University of California at Davis, Davis, CA 95616, USA. Xiang YK; Department of Pharmacology, University of California at Davis, Davis, CA 95616, USA. Rochet JC; Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 47907, USA. Engeland A; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.; Department of Pharmacoepidemiology, Norwegian Institute of Public Health, Oslo, Norway. Rizzu P; German Center for Neurodegenerative Diseases (DZNE), Tübingen 72076, Germany. Heutink P; German Center for Neurodegenerative Diseases (DZNE), Tübingen 72076, Germany. Bartels T; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.; Department of Neurology, Brigham and Women's Hospital, Boston, MA 02115, USA. Selkoe DJ; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.; Department of Neurology, Brigham and Women's Hospital, Boston, MA 02115, USA. Caldarone BJ; Department of Neurology, Brigham and Women's Hospital, Boston, MA 02115, USA.; Harvard NeuroDiscovery Center, Harvard Medical School, Boston, MA 02115, USA. Glicksman MA; Harvard NeuroDiscovery Center, Harvard Medical School, Boston, MA 02115, USA. Khurana V; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.; Department of Neurology, Brigham and Women's Hospital, Boston, MA 02115, USA.; Harvard Stem Cell Institute, Cambridge, MA 02138, USA. Schüle B; The Parkinson's Institute and Clinical Center, Sunnyvale, CA 94085, USA. Park DS; Brain and Mind Research Institute, Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada. Riise T; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.; The Norwegian Multiple Sclerosis Competence Center, Department of Neurology, Haukeland University Hospital, Norway. Scherzer CR; Neurogenomics Laboratory and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA. .; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.; Department of Neurology, Brigham and Women's Hospital, Boston, MA 02115, USA.
The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer's disease.
Autorzy:
Trombetta BA; MGH Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, United States of America. Carlyle BC; MGH Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, United States of America. Koenig AM; MGH Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, United States of America. Shaw LM; Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, United States of America. Trojanowski JQ; Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, United States of America. Wolk DA; Penn Memory Center, Department of Neurology, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, United States of America. LocascioJJ; MGH Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, United States of America. Arnold SE; MGH Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2018 Mar 05; Vol. 13 (3), pp. e0193707. Date of Electronic Publication: 2018 Mar 05 (Print Publication: 2018).
Measuring instrumental activities of daily living in non-demented elderly: a comparison of the new performance-based Harvard Automated Phone Task with other functional assessments.
Autorzy:
Marshall GA; Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA. .; Massachusetts Alzheimer's Disease Research Center, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA. . Aghjayan SL; Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA. Dekhtyar M; Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA. LocascioJJ; Massachusetts Alzheimer's Disease Research Center, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA. Jethwani K; Connected Health Innovation, Partners HealthCare, Harvard Medical School, Boston, MA, 02114, USA. Amariglio RE; Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.; Massachusetts Alzheimer's Disease Research Center, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA. Czaja SJ; Department of Psychiatry and Behavioral Sciences, Center on Aging, University of Miami Miller School of Medicine, Miami, FL, 33136, USA. Loewenstein DA; Department of Psychiatry and Behavioral Sciences, Center on Aging, University of Miami Miller School of Medicine, Miami, FL, 33136, USA. Johnson KA; Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.; Massachusetts Alzheimer's Disease Research Center, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA. Sperling RA; Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.; Massachusetts Alzheimer's Disease Research Center, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA. Rentz DM; Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.; Massachusetts Alzheimer's Disease Research Center, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2019 Jan 10; Vol. 11 (1), pp. 4. Date of Electronic Publication: 2019 Jan 10.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Presentations and outcomes of interstitial lung disease and the anti-Ro52 autoantibody.
Autorzy:
Sclafani A; Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital and Harvard Medical School, 100 Blossom St, Cox 201, Boston, MA, 02114, USA. . D'Silva KM; Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. Little BP; Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. Miloslavsky EM; Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. LocascioJJ; Biostatistics Center and Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. Sharma A; Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. Montesi SB; Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital and Harvard Medical School, 100 Blossom St, Cox 201, Boston, MA, 02114, USA.
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2019 Nov 12; Vol. 20 (1), pp. 256. Date of Electronic Publication: 2019 Nov 12.
Two decades of little change: An analysis of U.S. medical school basic science faculty by sex, race/ethnicity, and academic rank.
Autorzy:
Bennett CL; Brigham and Women's Hospital, Boston, Massachusetts, United States of America.; Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Harvard Medical School, Boston, Massachusetts, United States of America. Salinas RY; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, United States of America. LocascioJJ; Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Harvard Medical School, Boston, Massachusetts, United States of America. Boyer EW; Brigham and Women's Hospital, Boston, Massachusetts, United States of America.; Harvard Medical School, Boston, Massachusetts, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Jul 31; Vol. 15 (7), pp. e0235190. Date of Electronic Publication: 2020 Jul 31 (Print Publication: 2020).
CSP01, a Novel Superabsorbent Hydrogel, Reduces Colonic Transit Time in Patients With Chronic Idiopathic Constipation in a Randomized, Double-blind, Controlled Pilot Clinical Trial.
Autorzy:
Staller K; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. Barshop K; Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, MA, USA. Vélez C; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. Bailey A; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. LocascioJJ; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA. Chiquette E; Gelesis Inc, Boston, MA, USA. Kuo B; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Psychometric validation techniques applied to the IND-VFQ-33 visual function questionnaire: the Hyderabad ocular morbidity in the elderly study (HOMES).
Autorzy:
Mitchell W; Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Boston, USA. .; Harvard TH Chan School of Public Health, Harvard University, Boston, USA. . Marmamula S; Allen Foster Community Eye Health Research Centre, LV Prasad Eye Institute, Hyderabad, India.; Brien Holden Institute of Optometry and Vision Science, LV Prasad Eye Institute, Hyderabad, India.; Department of Biotechnology/Wellcome Trust India Alliance, LV Prasad Eye Institute, Hyderabad, India.; School of Optometry and Vision Science, University of New South Wales, Kensington, Australia. Zebardast N; Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Boston, USA.; Department of Ophthalmology, Harvard Medical School, Boston, USA. Ng W; University of Minnesota School of Public Health, University of Minnesota, Minneapolis, USA. LocascioJJ; Department of Neurology, MA General Hospital, Boston, USA. Kumbam T; Allen Foster Community Eye Health Research Centre, LV Prasad Eye Institute, Hyderabad, India. Brahmanandam S; Allen Foster Community Eye Health Research Centre, LV Prasad Eye Institute, Hyderabad, India. Barrenkala NR; Allen Foster Community Eye Health Research Centre, LV Prasad Eye Institute, Hyderabad, India.
Pokaż więcej
Źródło:
BMC medical research methodology [BMC Med Res Methodol] 2021 Feb 05; Vol. 21 (1), pp. 26. Date of Electronic Publication: 2021 Feb 05.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies